🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07522593
Starting soon Not applicable

Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors

NCT07522593 · tracked via the Priya Life Science China tracker
Sponsor
University of Southern Queensland
Phase
Not applicable
Started
2026-04-20
Last updated
2026-04-13

Condition(s) studied

Breast Cancer Survivor

Investigational drug(s) / intervention(s)

Baduanjin exercise

Baduanjin exercise: Baduanjin exercise is a low-to-moderate-intensity aerobic mind-body exercise that integrates movement (physical postures), meditation (focused attention), and controlled breathing. When practicing it, people stand in a position and perform eight movements, including 1) Two Hands Hold up the Heavens; 2) drawing the bow to shoot the eagle; 3)separate heaven and earth, 4)wise owl gazes backward or looking back, 5)sway the head and shake the tail, 6)two hands hold the keen to strengthen the kidneys and waist, 7) clench the fists and glare fiercely; 8) bouncing on the toes seven times.

Study summary

The goal of this clinical trial is to learn if Baduanjin exercise could be adopted by breast cancer survivors and improve their upper limb dysfunction. The main questions it aims to answer are:

* Does Baduanjin exercise improve upper limb dysfunction among breast cancer survivors?
* What problems or adverse events do participants have if they adopt Baduanjin exercise to improve upper limb dysfunction?

Participants will:

* Adopt Baduanjin exercise following an evidence-based intervention protocol
* Report their exercise frequency, length, and unexpected symptoms
* Receive three times assessment and follow-up every week

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Female, aged ≥ 18 years, diagnosed with non-metastatic unilateral Stage I-IIIa non-metastatic breast cancer, regardless of cancer type; 2. Surgeries completed at least two months before enrolment, and completion of radiotherapy and/or chemotherapy, with or without aromatase inhibitor therapy, upon enrolment; 3. Experiencing breast cancer treatment-related ULD, which is measured by the Disabilities of the Arm, Shoulder, and Hand (DASH) scale with a score of 20 or above; 4. Karnofsky Performance Status Scale (KPS), used to measure a patient's ability to perform daily activities and self-care independently, with a score of 90 or above; 5. Ability to read, write, and communicate in Chinese; 6. Have a personal cellphone; 7. Agree to participate in this study and provide written informed consent. Exclusion Criteria: 1. Any patient with a history of upper limb surgery, injury (fracture or shoulder dislocation), or other conditions not related to breast cancer treatments; 2. With other complications or adverse medical conditions that cannot perform BdjE, such as severe lymphedema, axillary web syndrome, or adhesive capsulitis; 3. Undergoing any physiotherapy for ULD or leading regular physical exercises in the previous three months; 4. Had skin grafting and autologous myocutaneous flap breast reconstruction; 5. Current clinical diagnosis of depression or anxiety, or receipt of active psychological treatment for significant mood or anxiety disorders; 6. Currently involved in other clinical studies.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Affiliated Hospital of Zunyi Medical University Zunyi Guizhou

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07522593 on ClinicalTrials.gov ↗ ← All trials in China